Related Articles
Protein arginine methyltransferase 5 is associated with malignant phenotype and peritoneal metastasis in gastric cancer
The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy
Prognostic impact of SET domain‑containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection
TMEM165, a Golgi transmembrane protein, is a novel marker for hepatocellular carcinoma and its depletion impairs invasion activity
Arginine methyltransferase inhibitor‑1 inhibits sarcoma viability in vitro and in vivo